In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates

In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates

The development of novel antibiotics is mandatory to curb the growing antibiotic resistance problem resulting in difficult-to-treat bacterial infections. Here, we have determined the spectrum of activity of cystobactamids and chelocardins, two novel and promising classes of molecules with different...

Full description

Bibliographic Details
Main Authors: Mariam Rima, Niels Pfennigwerth, Martina Cremanns, Katarina Cirnski, Saoussen Oueslati, Sören G. Gatermann, Nicola d’Amélio, Jennifer Herrmann, Rolf Müller, Thierry Naas
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Antibiotics
Subjects:
MDR
carbapenemase-producing Enterobacterales CPE
antimicrobial
in vitro susceptibility testing
Online Access:https://www.mdpi.com/2079-6382/12/8/1265

Similar Items

Similar Items